Loading clinical trials...
Loading clinical trials...
Open Labeled, Multicenter Phase I/II Study Evaluating the Dose Escalation/Safety of Cetuximab and Oxaliplatin/5-FU/FA/Irinotecan as First-Line Treatment of Metastatic Colorectal Cancer
Conditions
Interventions
Cetuximab
Locations
3
Germany
Universitaetsklinikum Carl Gustav Carus, Medizinische Klinik
Dresden, Saxony, Germany
Westdeutsches Tumorzentrum, Universitaetsklinikum Essen
Essen, Germany
Universitaetsklinik Mannheim GmbH, III. Medizinische Klinik
Mannheim, Germany
Start Date
January 1, 2007
Primary Completion Date
June 1, 2008
Last Updated
February 27, 2009
NCT04657068
NCT06625775
NCT06607458
NCT06820463
NCT07361003
NCT06792695
Lead Sponsor
Technische Universität Dresden
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions